KL
KCK Ltd Portfolio holdings
AUM
$18.3M
This Quarter Return
-28.03%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$142M
AUM Growth
–
Cap. Flow
+$142M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Sight Sciences
SGHT
|
$83.9M |
| 2 |
Neuropace
NPCE
|
$56.7M |
| 3 |
Immunic
IMUX
|
$667K |
| 4 |
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
|
$362K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sight Sciences
SGHT
$203M
| $83.9M | 59.26% |
+4,776,232
| New | +$83.9M |
|
|
2
Neuropace
NPCE
$302M
| $56.7M | 40.01% |
+5,621,111
| New | +$56.7M |
|
|
3
Immunic
IMUX
$78.8M
| $667K | 0.47% |
+69,704
| New | +$667K |
|
|
RNTX
4
Rein Therapeutics, Inc. Common Stock
RNTX
$31.1M
| $362K | 0.26% |
+646,817
| New | +$362K |
|